Open-Label Tolvaptan Study in Subjects With ADPKD (TEMPO 4/4)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.
ClinicalTrials.gov Identifier:
NCT01214421
First received: September 26, 2010
Last updated: February 28, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
No publications provided by Otsuka Pharmaceutical Development & Commercialization, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):